Usefulness of osteoprotegerin in assessing responses to neridronate treatment in Paget's disease of bone

F. M. Ulivieri, L. P. Piodi, G. Marotta, D. Marchelli, C. Corradini, L. Parravicini, C. Verdoia, P. Gerundini

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Osteoprotegerin (OPG) is a protein that inhibits of osteoclastogenesis. The aim this study was to evaluate the response of serum OPG levels to neridronate treatment in patients with Paget's disease of bone resistant to previous therapy. Nine patients (4 men) affected by active Paget's disease of bone (6 polyostotic, 3 monostotic) not responsive to clodronate were studied. Serum OPG, osteocalcin, total and bone isoenzyme of alkaline phosphatase (AP and BAP, respectively), and urinary deoxypyridinoline (DPD) were measured before and 5 months after neridronate treatment (100 mg/day, i.v. for two days). A scintigraphic activity index (SAI) was also calculated before treatment. Mean baseline OPG levels were within normal values and were not significantly different 5 months after neridronate treatment. In contrast, there were significant reductions in AP (41.9%, p

Original languageEnglish
Pages (from-to)192-194
Number of pages3
JournalJournal of Orthopaedics and Traumatology
Volume7
Issue number4
DOIs
Publication statusPublished - Dec 2006

Fingerprint

Osteitis Deformans
Osteoprotegerin
Clodronic Acid
Therapeutics
Osteocalcin
Serum
Osteogenesis
Isoenzymes
Alkaline Phosphatase
Reference Values
6-amino-1-hydroxyhexane-1,1-diphosphonate
Bone and Bones
Proteins

Keywords

  • Bone metabolism
  • Neridronate
  • Osteoprotegerin
  • Paget's disease of bone

ASJC Scopus subject areas

  • Surgery

Cite this

Usefulness of osteoprotegerin in assessing responses to neridronate treatment in Paget's disease of bone. / Ulivieri, F. M.; Piodi, L. P.; Marotta, G.; Marchelli, D.; Corradini, C.; Parravicini, L.; Verdoia, C.; Gerundini, P.

In: Journal of Orthopaedics and Traumatology, Vol. 7, No. 4, 12.2006, p. 192-194.

Research output: Contribution to journalArticle

Ulivieri, F. M. ; Piodi, L. P. ; Marotta, G. ; Marchelli, D. ; Corradini, C. ; Parravicini, L. ; Verdoia, C. ; Gerundini, P. / Usefulness of osteoprotegerin in assessing responses to neridronate treatment in Paget's disease of bone. In: Journal of Orthopaedics and Traumatology. 2006 ; Vol. 7, No. 4. pp. 192-194.
@article{8cc357e575f64d538e13b32bf1db614d,
title = "Usefulness of osteoprotegerin in assessing responses to neridronate treatment in Paget's disease of bone",
abstract = "Osteoprotegerin (OPG) is a protein that inhibits of osteoclastogenesis. The aim this study was to evaluate the response of serum OPG levels to neridronate treatment in patients with Paget's disease of bone resistant to previous therapy. Nine patients (4 men) affected by active Paget's disease of bone (6 polyostotic, 3 monostotic) not responsive to clodronate were studied. Serum OPG, osteocalcin, total and bone isoenzyme of alkaline phosphatase (AP and BAP, respectively), and urinary deoxypyridinoline (DPD) were measured before and 5 months after neridronate treatment (100 mg/day, i.v. for two days). A scintigraphic activity index (SAI) was also calculated before treatment. Mean baseline OPG levels were within normal values and were not significantly different 5 months after neridronate treatment. In contrast, there were significant reductions in AP (41.9{\%}, p",
keywords = "Bone metabolism, Neridronate, Osteoprotegerin, Paget's disease of bone",
author = "Ulivieri, {F. M.} and Piodi, {L. P.} and G. Marotta and D. Marchelli and C. Corradini and L. Parravicini and C. Verdoia and P. Gerundini",
year = "2006",
month = "12",
doi = "10.1007/s10195-006-0147-4",
language = "English",
volume = "7",
pages = "192--194",
journal = "Journal of Orthopaedics and Traumatology",
issn = "1590-9921",
publisher = "Springer-Verlag Italia",
number = "4",

}

TY - JOUR

T1 - Usefulness of osteoprotegerin in assessing responses to neridronate treatment in Paget's disease of bone

AU - Ulivieri, F. M.

AU - Piodi, L. P.

AU - Marotta, G.

AU - Marchelli, D.

AU - Corradini, C.

AU - Parravicini, L.

AU - Verdoia, C.

AU - Gerundini, P.

PY - 2006/12

Y1 - 2006/12

N2 - Osteoprotegerin (OPG) is a protein that inhibits of osteoclastogenesis. The aim this study was to evaluate the response of serum OPG levels to neridronate treatment in patients with Paget's disease of bone resistant to previous therapy. Nine patients (4 men) affected by active Paget's disease of bone (6 polyostotic, 3 monostotic) not responsive to clodronate were studied. Serum OPG, osteocalcin, total and bone isoenzyme of alkaline phosphatase (AP and BAP, respectively), and urinary deoxypyridinoline (DPD) were measured before and 5 months after neridronate treatment (100 mg/day, i.v. for two days). A scintigraphic activity index (SAI) was also calculated before treatment. Mean baseline OPG levels were within normal values and were not significantly different 5 months after neridronate treatment. In contrast, there were significant reductions in AP (41.9%, p

AB - Osteoprotegerin (OPG) is a protein that inhibits of osteoclastogenesis. The aim this study was to evaluate the response of serum OPG levels to neridronate treatment in patients with Paget's disease of bone resistant to previous therapy. Nine patients (4 men) affected by active Paget's disease of bone (6 polyostotic, 3 monostotic) not responsive to clodronate were studied. Serum OPG, osteocalcin, total and bone isoenzyme of alkaline phosphatase (AP and BAP, respectively), and urinary deoxypyridinoline (DPD) were measured before and 5 months after neridronate treatment (100 mg/day, i.v. for two days). A scintigraphic activity index (SAI) was also calculated before treatment. Mean baseline OPG levels were within normal values and were not significantly different 5 months after neridronate treatment. In contrast, there were significant reductions in AP (41.9%, p

KW - Bone metabolism

KW - Neridronate

KW - Osteoprotegerin

KW - Paget's disease of bone

UR - http://www.scopus.com/inward/record.url?scp=33846076525&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846076525&partnerID=8YFLogxK

U2 - 10.1007/s10195-006-0147-4

DO - 10.1007/s10195-006-0147-4

M3 - Article

VL - 7

SP - 192

EP - 194

JO - Journal of Orthopaedics and Traumatology

JF - Journal of Orthopaedics and Traumatology

SN - 1590-9921

IS - 4

ER -